Everest Organics Ltd

Everest Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Everest Organics Ltd’s stock price declined to a fresh 52-week low of Rs.219 on 27 March 2026, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector and broader market weakness. The stock’s performance continues to trail key benchmarks amid subdued financial metrics and technical indicators.

Everest Organics Ltd’s stock price declined sharply to a new 52-week low of Rs.227 on 24 March 2026, marking a significant milestone in its recent downward trajectory. The stock underperformed its sector and has been on a losing streak over the past two days, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry.

Everest Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 16 Mar 2026. This revision reflects deteriorating technical indicators, subdued financial trends, and persistent valuation concerns despite some recent positive quarterly results.

Everest Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Everest Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.

Everest Organics Ltd., a Telangana-based active pharmaceutical ingredients manufacturer with a market capitalisation of ₹374.00 crores, reported a disappointing third quarter for FY2026, with net profit collapsing 68.97% quarter-on-quarter to ₹0.36 crores from ₹1.16 crores in Q2 FY26. The sharp decline came despite marginal revenue growth on a year-on-year basis, as operating margins contracted significantly and tax expenses surged to an unusually high 65.38% of profit before tax.

Everest Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reported a mixed set of quarterly results for December 2025, reflecting a shift in its financial trend from very positive to positive. While the company has demonstrated robust growth in net sales over nine months and improved profitability metrics, recent quarterly figures reveal some contraction, signalling challenges ahead for investors.

Everest Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. While the rating was revised on this date, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 16 February 2026, providing investors with an up-to-date view of the company’s position.

Everest Organics Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This transition, coupled with its recent market performance and peer comparisons, offers investors a fresh perspective on the stock’s price attractiveness amid a challenging market backdrop.

Everest Organics Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Everest Organics Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Aug 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Everest Organics Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 05 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 January 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.